Basic and Clinical Science

Blog
September 16, 2019

This has been a landmark year for HIV treatment; a seven-year study confirmed that taking ART can prevent transmission between gay couples and a second patient has been effectively cured of HIV after receiving a stem cell transplant as a cancer treatment.

Opportunity
September 5, 2019
Panagora South Africa has a Collaboration and Learning Hub that supports the USAID/South Africa Health Office with Expert Technical Services. This includes two activities, Technical Support Services (TSS) and Monitoring, Evaluation, Research and Learning (MERL), both of which help USAID meet its HIV and TB programs goals. Panagora is actively looking for creative, dynamic, results-focused and experienced professionals for a number of positions.
Resource
September 2, 2019

The World Health Organization (WHO) convened a Guideline Development Group (GDG) meeting from 29 to 31 July 2019 to review global guidance on contraceptive eligibility for women at high risk of HIV acquisition to and determine whether revisions to the fifth edition of the Medical eligibility crit

News
September 2, 2019

Women at high risk for HIV infection can use any form of reversible hormonal contraception without any restrictions, including progestogen-only injectables, implants, and intrauterine devices (IUDs), the World Health Organization (WHO) said.

Resource
August 29, 2019

The development of topical inserts for the prevention of sexually transmitted infections (STIs), particularly human immunodeficiency virus (HIV), represents a promising alternative to oral and parenteral pre-exposure prophylaxis (PrEP) dosage forms.

Resource
August 26, 2019
The Eastern Cape province of South Africa has one of the highest burdens of HIV in the world. Emergency Departments (EDs) can serve as optimal clinical sites for the identification of new HIV infections and entry into care. We sought to determine the current burden of HIV disease among ED patients in the Eastern Cape.
Resource
August 26, 2019

Broadly neutralizing antibodies (bnAbs) are currently under investigation as a therapy for HIV-1 infection and recent clinical trials have shown prolonged viral suppression by bnAbs during antiretroviral treatment interruption.

News
August 25, 2019
High HIV prevalence and attrition along the treatment cascade among emergency department (ED) populations highlights potential role of HIV services in theses settings.
News
August 23, 2019

Drugs work stunningly well to control HIV—but not in everyone, and not without side effects. That's why a small cadre of patients known as elite controllers has long fascinated researchers: Their immune system alone naturally suppresses HIV for decades without drugs.